[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.127.188. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,743
Citations 0
Editorial
May 2016

Genome-wide Significant Associations for Cannabis Dependence SeverityRelevance to Psychiatric Disorders

Author Affiliations
  • 1Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Wales
JAMA Psychiatry. 2016;73(5):443-444. doi:10.1001/jamapsychiatry.2016.0046

Cannabis is the most widely used illicit drug in the world, and debate about the impact of its use has been fueled by policies of decriminalization and legalization. The changing legal context reiterates the importance of understanding the factors that predispose a person to use cannabis, the potential for dependence, and its associations with adverse outcomes including mental illness. The article by Sherva and colleagues1 in this issue of JAMA Psychiatry uses molecular genetics to address some of these issues by reporting the results of a genome-wide association study (GWAS) of cannabis dependence and seeking evidence for genetic overlap with 5 mental disorders.

First Page Preview View Large
First page PDF preview
First page PDF preview
×